X

Analysis

General Motors (GM) Q3 earnings preview: What changed since last report

After reaching a tentative truce agreement with the striking workers, General Motors (NYSE: GM) is preparing to report third-quarter results…

Walgreens Boots (WBA) earnings preview: No surprises expected in Q4 report

It has been a tough year for Walgreens Boots Alliance (NASDAQ: WBA) so far, with the stock losing steadily amid…

AT&T (T) earnings preview: Q3 results to be influenced by these factors

AT&T (NYSE: T) will be reporting its third-quarter results on Monday before the opening bell, days after the communications firm…

Amazon (AMZN) Q3 earnings preview: Key factors to watch for

Amazon (NASDAQ: AMZN) disappointed the market when it released second-quarter results a few months ago, with a surprise earnings miss…

Will wireless prowess help Xilinx (XLNX) overcome China issues in Q2?

Xilinx (NASDAQ: XLNX) disappointed the market a few months ago when it issued below-consensus guidance for the September-quarter and the…

PayPal (PYPL) Q3 earnings preview: Investments, volume to influence results

After recording double-digit earnings and revenue growth in the second quarter, PayPal Holdings (NASDAQ: PYPL) lowered its full-year revenue guidance…

Biogen (BIIB) earnings preview: Will stock bounce back after Q3 report?

The market value of pharma giant Biogen, Inc. (NASDAQ: BIIB) declined by a third in March when the stock suffered…

Understanding the pros and cons of investing in Alibaba (BABA) stock

Rarely do market watchers recommend a stock so overwhelmingly as they have done in the case of Chinese e-commerce firm…

Why is AMD a better investment option after de-escalation of tariff war?

After ending the downtrend that lasted for several weeks, shares of Advanced Micro Devices (NASDAQ: AMD) finally bounced back a…

Can Intuitive Surgical (ISRG) thrive on the health of da Vinci system in Q3?

Intuitive Surgical (NASDAQ: ISRG), a market leader in robotic-assisted surgical systems, continues to scale new heights aided by the success…

A bleak Q3 awaits Bank of America (BAC) amid low interest rates, trade dispute

The general mood is not very encouraging ahead of the earnings season for banks, which is about to start, and…

Twitter steers downward on weak revenue growth rate

Twitter Inc. (NYSE: TWTR) stock has fallen over 13% in the past month despite rising over 38% in the year…

Retailers take strong stand against guns and e-cigs; stocks remain steady

Two of the biggest controversies in recent times have been with regards to guns and e-cigarettes. Several deaths have been…

Nio deliveries finally improve, but will this help outplay Tesla?

Nio Inc. (NYSE: NIO) stock continued its gains on Tuesday as the ramp-up of its premium electric SUV, ES6, drove…

SmileDirectClub stock hits its lowest since IPO amid analyst initiations

SmileDirectClub (NASDAQ: SDC) stock has fallen 32% to $11.20 on Tuesday, which is the teledentistry company's lowest since the initial…

PepsiCo: How the snack business steered the company away from rough waters

PepsiCo Inc. (NYSE: PEP) is a leader in its industry and the company has delivered healthy results consistently. This growth…

General Motors: A look at deliveries over the past year

General Motors (NYSE: GM) is in the midst of a dispute with labor unions that has now entered its fourth…

Softbank’s hopes are now pinned on this rapid-growth “WeWork-like” unicorn

It’s been a pretty rough year so far for Japanese conglomerate Softbank, which invests primarily in technology firms around the…

Can beer companies expect new fizz from their cannabis ventures?

The beer business is an area that usually remains unaffected by the general ups and downs of the market as…

Kroger might need to do more than cost-cutting to bounce back

After registering record e-commerce sales last year, grocery store chain Kroger (NYSE: KR) has been on a mission to transform…

Strong pipeline and innovation make Novartis a sure bet, despite setbacks

The uncertainties surrounding drug development and intense competition are the primary challenges facing pharmaceutical companies, which also prompt investors to…